Next Article in Journal
A Study of Mucoadhesive Bond Strength of Buccoadhesive Compacts for Systemic Drug Delivery: In-vitro/ In-vivo correlation
Previous Article in Journal
Synthesis and In Vitro Evaluation of Chitosan-Thioglycolic Acid Conjugates
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nitraminanaloge Suosan-Derivate als potentielle Süßstoffe

Institut für Pharmazeutische Chemie der Westfälischen Wilhelms-Universität Münster, Hittorfstr. 58-62, D-48149 Münster, Bundesrepublik Deutschland
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2001, 69(2), 119-122; https://doi.org/10.3797/scipharm.aut-01-13
Submission received: 20 March 2001 / Accepted: 18 April 2001 / Published: 30 June 2001

Abstract

Substituted phenylaminocarbonylaziridines are reacted with N-nitro-ethylcarbamate and then with ammonia to give N-aryl-N′-nitroaminoethyl-ureas 5-11 after acidification. 5 and 6 have a sweet taste, 7 is bitter.
Keywords: Arylaminocarbonylaziridines; N-aryl- N′-nitroaminoethyl-ureas Arylaminocarbonylaziridines; N-aryl- N′-nitroaminoethyl-ureas

Share and Cite

MDPI and ACS Style

Unterhalt, B.; Adam, T.; Bagherzadeh, H. Nitraminanaloge Suosan-Derivate als potentielle Süßstoffe. Sci. Pharm. 2001, 69, 119-122. https://doi.org/10.3797/scipharm.aut-01-13

AMA Style

Unterhalt B, Adam T, Bagherzadeh H. Nitraminanaloge Suosan-Derivate als potentielle Süßstoffe. Scientia Pharmaceutica. 2001; 69(2):119-122. https://doi.org/10.3797/scipharm.aut-01-13

Chicago/Turabian Style

Unterhalt, B., T. Adam, and H. Bagherzadeh. 2001. "Nitraminanaloge Suosan-Derivate als potentielle Süßstoffe" Scientia Pharmaceutica 69, no. 2: 119-122. https://doi.org/10.3797/scipharm.aut-01-13

Article Metrics

Back to TopTop